Clinical Trial Update: Omega-3, Nigella Sativa, Indian Costus, Quinine, Anise Seed, Deglycyrrhizinated Licorice, Artemisinin, Febrifugine on Immunity of Patients With (COVID-19) [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/Phase 3 clinical trial evaluating multiple natural products and compounds (Omega-3, Nigella sativa, Indian costus, quinine, anise seed, deglycyrrhizinat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immunodeficiency

Drugs mentioned

• Anise seed (Pimpinella anisum (Anise) seed)
• Artemisinin (Artemisinin)
• Deglycyrrhizinated licorice (Deglycyrrhizinated licorice (DGL))
• Febrifugine (Febrifugine)
• Indian costus (Costus (Indian costus))
• Nigella Sativa (Nigella sativa)
• Omega-3 fatty acids (omega-3 fatty acids)
• Quinine (quinine)

Snippet

Sponsor: Beni-Suef University | Conditions: Covid19, Immunodeficiency | Phase 2, Phase 3 | Status: COMPLETED